U.S. flag

An official website of the United States government

GTR Home > Tests > MVL Vision Panel

Performance Characteristics



  • Entire test performed in-house

Analytical Validity


Our MVL Vision Panel (v18) consists of 1024 genes with an average coverage of 500 reads and at least 30X coverage in >96% of the panel. Targeted regions cover all exons, exon-intron boundaries, and relevant, deep-intronic regions. Identified mutations and novel variations are confirmed by Sanger sequencing. The sensitivity of DNA sequencing is 99% for the detection of nucleotide base changes, small deletions and insertions in the regions analyzed. Multiple exon deletions, multiple exon insertions, and complete deletion of one allele may not be identified using these methods.


Not provided

Proficiency Testing (PT)

Is proficiency testing performed for this test? Help

FDA Regulatory Clearances of the Test


Not provided

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.